Mild to moderate dysplasia at surgical margin is a significant indicator of survival in patients with oral cancer.

OBJECTIVE: The objective of this study was to investigate the significance of mild and moderate dysplasia at the surgical margin with regard to survival and locoregional recurrence. STUDY DESIGN: We investigated cases of primary oral squamous cell carcinoma with negative margins retrospectively from the database of a tertiary cancer hospital. All patients had been treated between January 2010 and December 2012, and margin dysplasia was investigated in a multivariate analysis for locoregional recurrence and overall survival. RESULTS: Of a total of 425 patients who fulfilled the inclusion criteria, 28 patients had mild dysplasia, and 29 patients had moderate dysplasia; median period of follow-up was 46.63 ± 10.04 (standard deviation) months. Most of the patients with mild and moderate dysplasia in the margin were tobacco users (P = .007). Univariate analysis showed lower rates of survival among the patients with margin dysplasia (mild + moderate) (P = .043), and the multivariate cox regression revealed moderate dysplasia at the margin as an independent significant factor for survival (P < .0001) when adjusted with other cofounders. CONCLUSIONS: Patients with mild or moderate dysplasia at surgical margin were often tobacco users, and moderate dysplasia in the margin is an independent significant indicator for survival of patients with oral cancer in this single-institution, retrospective study.

Oral hybrid verrucous carcinoma: a clinical study.

Hybrid Verrucous Carcinoma is an uncommon tumour wherein Verrucous Carcinoma (VC) is coexisting with conventional Squamous Cell Carcinoma (SCC) within same maternal field. The heterogeneous nature, infrequency of occurrence and the difficulties associated with diagnosis and management of this tumor is discussed through a retrospective study. Patients of primary hybrid VC treated from Jan 2010 to May 2013 at a tertiary institute were analyzed on multivariate cox regression model. During the above mentioned period; 37 patients of hybrid VC were reported; 18(48.6 %) were male and 19(51.3 %) were female. Age ranged between 33 years to 78 years. Median follow up period was 32 months. T stage status and Stage grouping was not statistically significant for mortality (p value: 0.338). In the multivariate cox-regression model, the presence of second primary oral cancer was significantly associated with mortality, adjusted HR; 23.10 (95 % CI: 1.73, 307.65) (p = 0.017). Tumour staging is often unreliable in predicting prognosis of hybrid VC, occurrence of second primary oral cancer and recurrence appears to be significant factors effecting prognosis.